Přihlásit se Zaregistrujte se zdarma

EBITDA margin společnosti PureTech Health Plc

Jaká je hodnota metriky EBITDA margin společnosti PureTech Health Plc?

Hodnota metriky EBITDA margin společnosti PureTech Health Plc je -38,254.70%

Jaká je definice metriky EBITDA margin?



EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.

ttm (trailing twelve months)

EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.

EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.

EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.

EBITDA margin společností v sektoru Health Care sektor na LSE ve srovnání se společností PureTech Health Plc

Čemu se věnuje společnost PureTech Health Plc?

PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophrenia and dementia-related psychosis; a hydrogel platform technology to treat obesity and other chronic metabolic diseases; a regenerative biology platform for androgenetic alopecia, epithelial ageing, and other medical conditions; a immunomodulation platform to treat chronic and acute inflammatory disorders; therapies for immune-mediated diseases based on a rationally-defined consortia of human microbiome-derived bacteria; and a digital treatments to treat cognitive dysfunction associated with neurology and psychiatry conditions. It also provides hematopoietic stem cell based therapies to treat hematological malignancies; a voice-based technology platform to measure health when a person speaks; and a technology platform for the oral delivery of biologics, vaccines, and other drugs. In addition, the company is developing LYT-100, an oral small molecule drug candidate to treat lymphedema, and other lymphatic flow disorders; LYT-200, a IgG4 monoclonal antibody to target galectin-9; LYT-210, a IgG1 monoclonal antibody; Glyph, a synthetic lymphatic targeting chemistry platform; milk exosome-based technology to enable the oral administration of macromolecule therapeutic payloads; and meningeal lymphatics platform to treat Alzheimer's and Parkinson's diseases. PureTech Health plc has collaboration and license agreements with Boehringer Ingelheim International GMBH; Roche Holding AG; Eli Lilly and Company; Imbrium Therapeutics L.P.; and Shionogi & Co., Ltd. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Firmy s metrikou ebitda margin podobnou společnosti PureTech Health Plc



  • Hodnota metriky EBITDA margin společnosti Seres Therapeutics Inc je -40,528.07%
  • Hodnota metriky EBITDA margin společnosti Protean je -40,131.16%
  • Hodnota metriky EBITDA margin společnosti FYI Resources je -40,128.76%
  • Hodnota metriky EBITDA margin společnosti Impact Minerals je -39,193.47%
  • Hodnota metriky EBITDA margin společnosti Denali Therapeutics Inc je -38,414.68%
  • Hodnota metriky EBITDA margin společnosti BerGenBio ASA je -38,325.06%
  • Hodnota metriky EBITDA margin společnosti PureTech Health Plc je -38,254.70%
  • Hodnota metriky EBITDA margin společnosti Galileo Mining Ltd je -37,996.06%
  • Hodnota metriky EBITDA margin společnosti Trillium Therapeutics je -37,581.76%
  • Hodnota metriky EBITDA margin společnosti The9 je -37,275.85%
  • Hodnota metriky EBITDA margin společnosti Zonetail je -37,249.56%
  • Hodnota metriky EBITDA margin společnosti Canoo je -37,055.13%
  • Hodnota metriky EBITDA margin společnosti Opthea je -36,842.07%